» Articles » PMID: 14647400

Amplification of RNA Transcripts Using Terminal Continuation

Overview
Journal Lab Invest
Specialty Pathology
Date 2003 Dec 3
PMID 14647400
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

A new methodology has been developed to amplify RNA from minute amounts of starting material. Specifically, an efficient means of second-strand (ss) cDNA synthesis using a sequence-specific 'terminal continuation' (TC) method is demonstrated. An RNA synthesis promoter is attached to the 3' and/or 5' region of cDNA utilizing the TC mechanism. The orientation of amplified RNAs is 'antisense' or a novel 'sense' orientation. TC RNA amplification is utilized for many downstream applications including gene expression profiling, cDNA microarray analysis, and cDNA library/subtraction library construction. Synthesized sense TC-amplified RNA can also be used as a template for in vitro protein translations and downstream proteomic applications. The TC RNA amplification methodology offers high sensitivity, flexibility, and throughput capabilities. A likely mechanism is that the TC primer binds preferentially to GC-rich CpG islands flanking 5' regions of DNA that contain promoter sequences. Following TC RNA amplification, a large proportion of genes can be assessed quantitatively as evidenced by bioanalysis and cDNA microarray analysis in mouse and human postmortem brain tissues.

Citing Articles

Maternal choline supplementation rescues early endosome pathology in basal forebrain cholinergic neurons in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.

Gautier M, Kelley C, Lee S, Mufson E, Ginsberg S Neurobiol Aging. 2024; 144:30-42.

PMID: 39265450 PMC: 11490376. DOI: 10.1016/j.neurobiolaging.2024.09.002.


Decoding the epitranscriptional landscape from native RNA sequences.

Jenjaroenpun P, Wongsurawat T, Wadley T, Wassenaar T, Liu J, Dai Q Nucleic Acids Res. 2020; 49(2):e7.

PMID: 32710622 PMC: 7826254. DOI: 10.1093/nar/gkaa620.


Expression profiling of precuneus layer III cathepsin D-immunopositive pyramidal neurons in mild cognitive impairment and Alzheimer's disease: Evidence for neuronal signaling vulnerability.

He B, Perez S, Lee S, Ginsberg S, Malek-Ahmadi M, Mufson E J Comp Neurol. 2020; 528(16):2748-2766.

PMID: 32323319 PMC: 7492791. DOI: 10.1002/cne.24929.


Brain-derived neurotrophic factor (BDNF) and TrkB hippocampal gene expression are putative predictors of neuritic plaque and neurofibrillary tangle pathology.

Ginsberg S, Malek-Ahmadi M, Alldred M, Chen Y, Chen K, Chao M Neurobiol Dis. 2019; 132:104540.

PMID: 31349032 PMC: 6834890. DOI: 10.1016/j.nbd.2019.104540.


Long-term effects of maternal choline supplementation on CA1 pyramidal neuron gene expression in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.

Alldred M, Chao H, Lee S, Beilin J, Powers B, Petkova E FASEB J. 2019; 33(9):9871-9884.

PMID: 31180719 PMC: 6704451. DOI: 10.1096/fj.201802669RR.